<DOC>
	<DOCNO>NCT01801397</DOCNO>
	<brief_summary>Study Title : A pilot study evaluate effect Forsteo® ( Teriparatide , 1-34 rh-PTH ) Anorexia Nervosa patient low mineral density increase bone fragility ( FAN-Trial ) Short Title/Study ID : FAN-Trial / Psy-Rheu_2011/1 Indication : Low bone mineral density ( Z-Score &lt; -1.5 T-Score &lt; -1.5 available ) fragility fracture low bone mineral density ( Z-Score &lt; -2.5 T-Score &lt; -2.5 available ) without fragility fracture Anorexia Nervosa patient Trial Design : Open-label , single-centre pilot study study drug treatment duration 24 month . Study Center : Single-centre ( University Hospital Zürich ) Investigator ( ) /Authors : PD Dr. med Gabriella F. Milos ( Principle Investigator author ) , Dept Psychiatry , Centre Eating Disorders , University Hospital Zürich , CH-8091 Zürich Dr. med . Diana P. Frey ( Co-Investigator author ) , Dept . Rheumatology , University Hospital Zürich , CH-8091 Zürich PD Dr. med . Daniel Uebelhart ( author ) , SUVA Fribourg , CH-1701 Fribourg Objective ( ) /Outcome ( ) : Primary endpoint : •To ass efficacy Teriparatide ( Forsteo® ) increase bone mineral density lumbar spine , total hip femoral neck patient anorexia nervosa low bone density month 12 24 . Secondary endpoint : - To assess change blood biomarkers - To assess change whole body composition - To assess incidence new fragility fracture - To assess change bone structure - To assess change EDE-Q - Longterm safety tolerability Teriparatide ( Forsteo® ) patient AN Assessments primary endpoint : •BMD lumbar spine , total hip femoral neck , measure DXA Assessments secondary endpoint : - bone resorption bone formation marker measure urine serum - whole body composition measure DXA - New clinical peripheral vertebral fracture - HRqCT tibia forearm - EDE-Q Score month 12 24 Safety measurement : - Safety lab ( blood urine ) - Clinical adverse event monitor visit Number Subjects : 10 Diagnosis Main Inclusion Criteria : - Women , age &gt; 18 &lt; 35 year - Having severe anorexia nervosa ( AN ) ( DSM-IV-R ) &gt; 12 month screen - Presenting low bone mineral density ( define Z-Score &lt; -2.5 T-Score &lt; -2.5 available ) least one assessed localization ( lumbar spine L1 - L4 , total hip , femoral neck ) without previous fragility fracture - low bone mineral density ( define Z-Score &lt; -1.5 T-Score &lt; -1.5 available ) least one assessed localization ( lumbar spine L1 - L4 , total hip , femoral neck ) least one previous fragility fracture - In- out-patients Centre Eating Disorders Clinic Psychiatry Psychotherapy University Hospital Zurich . Main Exclusion Criteria : - Metabolic bone diseases primary osteoporosis ( include hyperparathyroidism , osteomalacia , Paget 's disease bone ) , pre-existing hypercalcemia , severe renal impairment ( GFR &lt; 30 ml/min ) , prior external beam implant radiation therapy skeleton , skeletal malignancy bone metastasis , unknown elevation serum alkaline phosphatase , severe psychiatric diseases AN , drug addiction , HIV positive patient , pregnancy , open epiphyses - Incapacity understand aim study patient willing collaborate . Study Product , Dose , Route , Regimen : Teriparatide ( Forsteo® ) , 20µg s.c. daily 24 month . Duration study : 24 month . Reference therapy , Dose , Route , Regimen : - Trial medicinal product</brief_summary>
	<brief_title>A Pilot Study Evaluate Effect Forsteo ( Teriparatide , 1-34-rh-PTH ) Anorexia Nervosa Patients With Low Bone Mineral Density Increased Bone Fagility ( FAN-Trial )</brief_title>
	<detailed_description />
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Inclusion criterion : •Women , age &gt; 18 &lt; 35 year Having severe anorexia nervosa ( AN ) ( DSMIVR ) &gt; 12 month screen Presenting low bone mineral density ( define ZScore &lt; 2.5 TScore &lt; 2.5 available ) least one assessed localization ( lumbar spine L1 L4 , total hip , femoral neck ) without previous fragility fracture low bone mineral density ( define ZScore &lt; 1.5 TScore &lt; 1.5 available ) least one assessed localization ( lumbar spine L1 L4 , total hip , femoral neck ) least one previous fragility fracture In outpatient Centre Eating Disorders Clinic Psychiatry Psychotherapy University Hospital Zurich . Exclusion criterion : Metabolic bone diseases primary osteoporosis ( include hyperparathyroidism , osteomalacia , Paget 's disease bone ) , preexist hypercalcemia , severe renal impairment ( GFR &lt; 30 ml/min ) , prior external beam implant radiation therapy skeleton , skeletal malignancy bone metastasis , unknown elevation serum alkaline phosphatase , severe psychiatric diseases AN , drug addiction , HIV positive patient , pregnancy , open epiphysis •Incapacity understand aim study patient willing collaborate .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>